findmyKOL

Vikas Singh, MD

Basic profile

Hematology / Oncology

ORCID↗NPI↗
✓ Full record
RegionLouisville, KY · SoutheastSpecialtyHematology / OncologyFocusOncology
Active KOLfindmyKOL type: RegionalLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Vikas Singh is an Oncology physician. OpenAlex indexes 25 publications with 597 citations (h-index 5).

Overview

Scholarship

indexed output and impact (OpenAlex)
25publications

Distinct works indexed by OpenAlex, matched via ORCID.

597citations

Total citations across indexed works.

5h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
60companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

529 S Jackson St
Louisville, KY 402023229

Telephone

502-562-2902

Registry record last updated 6 Apr 2018.

View the NPPES registry record

Industry payments

60 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    33.8%
    Opioid Agonist17.6%
    Oxycodone Hcl48%Tramadol Hcl21%Oxycodone-Acetaminophen16%Morphine Sulfate Er9%Fentanyl7%
    Part D<11 patients
    Gabapentinoids9.6%
    Gabapentin100%
    Part D≥33 patients

    + 3 more classes in this area

  • Metabolism & gastrointestinal

    29%
    Corticosteroid10%
    Prednisone100%
    Part D≥40 patients
    Potassium supplement6.2%
    Potassium Chloride77%Klor-Con M2023%
    Part D<11 patients

    + 5 more classes in this area

  • Cancer & immunology

    10.9%
    Cytochrome P450 17A1 Inhibitor3.7%
    Abiraterone Acetate100%
    Part D<11 patients
    Aromatase Inhibitor3.1%
    Anastrozole100%
    Part D<11 patients

    + 2 more classes in this area

Where care is delivered (Part B)19.5% facility · 80.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”